Start your own journey to clinic

Please provide us with a few details so that we can match you with the right expert in your field.

*Required

Thank you, your request has been received.

We're busy connecting you with an expert, who will be in touch as soon as possible.

Oops! Something went wrong while submitting the form. Please try again or email us at webenquiries@conceptlifesciences.com
Brochure

Brochure

Neuroinflammation Brochure

Neuroinflammation is not only a consequence of, but also a key driver of neurodegeneration. In neuroinflammation, multiple signalling pathways become chronically dysregulated in both astrocytes and microglia, triggering the excessive and continued release of pro-inflammatory cytokines, chemokines, and neurotoxic molecules, which eventually leads to neuronal damage and degeneration. Modulation of these inflammatory pathways is a promising strategy for the treatment of neurodegenerative diseases such as Alzheimer’s disease and Parkinson’s disease. To support the discovery and preclinical development of novel therapeutics targeting neuroinflammation, we have developed a platform of in vitro and ex vivo assays that harnesses models of increasing physiological relevance and complexity, to suit your stage in the drug development journey. By meticulously tailoring these assays to your requirements and by coupling them with a flexible range of redouts powered by our cutting-edge technologies, we deliver high-quality data and accelerate your progression to the clinic.

Alternatively, search our entire resource library below

Show filters
View all
Category one
Category two
Category three
Category four
Search
Clear
Resource type
Clear
Related service line
Clear
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Tag
Showing 0 items
No results found.
There are no results with this criteria. Try changing your search.